A new fat-dissociation method to detect lymph nodes in colorectal cancer: a prospective randomized study.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
19 11 2020
19 11 2020
Historique:
received:
06
02
2020
accepted:
26
10
2020
entrez:
20
11
2020
pubmed:
21
11
2020
medline:
14
1
2021
Statut:
epublish
Résumé
Histological examination of the lymph nodes (LNs) is crucial to determine the colorectal cancer (CRC) stage. We previously reported a new fat-dissociation method (FM) to detect LNs from surgically resected mesentery. This study aimed to examine the effectiveness of FM compared with that of conventional palpation method (PM) in CRC. This single-center, open-label, randomized controlled study was performed at Osaka International Cancer Institute in Japan in 2014. Randomization was performed using a computer-generated permuted-block sequence. Patients were stratified by surgical procedures and the LN dissection area. The primary endpoint was the time required for LN identification. The secondary endpoint was the number of LNs and 5-year cancer-specific survival. The 130 enrolled patients were randomly assigned in a 1:1 ratio to the FM and the PM groups. LN identification times were 45 (range 15-80) and 15 (range 7-30) minutes in the PM and the FM groups, respectively (P < 0.001). In the PM group, body mass index and identification time were correlated (P = 0.047). The number of LN which could be examined pathologically was 16 (range 2-48) and 18 (range 4-95) in the PM and FM groups, respectively (P = 0.546). In right-sided CRC, the number of LNs was higher in the FM group than in the PM group (P = 0.031). Relapse-free survival rates and cancer-specific survival rates did not differ between the groups. In conclusion, FM reduced the time required for LN detection without reducing the number of detected LNs, making it is a useful method to detect LNs in surgical specimens.
Identifiants
pubmed: 33214579
doi: 10.1038/s41598-020-77195-8
pii: 10.1038/s41598-020-77195-8
pmc: PMC7678840
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
20205Références
Int J Clin Oncol. 2015 Apr;20(2):207-39
pubmed: 25782566
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
Cancer Epidemiol. 2016 Dec;45:65-70
pubmed: 27716537
Ann Oncol. 2012 Oct;23(10):2479-2516
pubmed: 23012255
Oncol Rep. 2014 Sep;32(3):922-6
pubmed: 25017814
Cancer. 2011 Oct 1;117(19):4365-74
pubmed: 21437889
Int J Clin Oncol. 2012 Feb;17(1):1-29
pubmed: 22002491
Lung Cancer. 2016 Jul;97:1-7
pubmed: 27237020
Int J Clin Oncol. 2018 Feb;23(1):1-34
pubmed: 28349281
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Gynecol Oncol. 2016 Oct;143(1):54-59
pubmed: 27498395
Surg Today. 2020 Jul;50(7):726-733
pubmed: 31912338
Dis Colon Rectum. 1994 Mar;37(3):219-23
pubmed: 8137667
World J Gastrointest Surg. 2020 Jun 27;12(6):277-286
pubmed: 32774766
Ann Surg Oncol. 2012 Nov;19(12):3865-70
pubmed: 22618721
Ann Oncol. 2013 Oct;24 Suppl 6:vi81-8
pubmed: 24078665
Clin Cancer Res. 2016 Jul 1;22(13):3201-8
pubmed: 26831719
Ann Surg Oncol. 2011 Jul;18(7):1891-8
pubmed: 21290195
JAMA Oncol. 2018 Nov 1;4(11):1553-1568
pubmed: 29860482
Dis Colon Rectum. 2013 Sep;56(9):1028-35
pubmed: 23929011
Arch Pathol Lab Med. 2001 May;125(5):642-5
pubmed: 11300935
Int J Clin Oncol. 2017 Feb;22(1):3-10
pubmed: 27549784
Ann Oncol. 2013 Oct;24 Suppl 6:vi64-72
pubmed: 24078664
Ann Oncol. 2014 Sep;25 Suppl 3:iii1-9
pubmed: 25190710
Arch Pathol Lab Med. 2009 Jan;133(1):83-6
pubmed: 19123742
J Am Coll Surg. 1994 Mar;178(3):223-8
pubmed: 8149012